Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 8;9(1):e3398.
doi: 10.1371/journal.pntd.0003398. eCollection 2015 Jan.

Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever

Affiliations

Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever

Giovanni Lo Iacono et al. PLoS Negl Trop Dis. .

Abstract

Background: Zoonotic infections, which transmit from animals to humans, form the majority of new human pathogens. Following zoonotic transmission, the pathogen may already have, or may acquire, the ability to transmit from human to human. With infections such as Lassa fever (LF), an often fatal, rodent-borne, hemorrhagic fever common in areas of West Africa, rodent-to-rodent, rodent-to-human, human-to-human and even human-to-rodent transmission patterns are possible. Indeed, large hospital-related outbreaks have been reported. Estimating the proportion of transmission due to human-to-human routes and related patterns (e.g. existence of super-spreaders), in these scenarios is challenging, but essential for planned interventions.

Methodology/principal findings: Here, we make use of an innovative modeling approach to analyze data from published outbreaks and the number of LF hospitalized patients to Kenema Government Hospital in Sierra Leone to estimate the likely contribution of human-to-human transmission. The analyses show that almost [Formula: see text] of the cases at KGH are secondary cases arising from human-to-human transmission. However, we found much of this transmission is associated with a disproportionally large impact of a few individuals ('super-spreaders'), as we found only [Formula: see text] of human cases result in an effective reproduction number (i.e. the average number of secondary cases per infectious case) [Formula: see text], with a maximum value up to [Formula: see text].

Conclusions/significance: This work explains the discrepancy between the sizes of reported LF outbreaks and a clinical perception that human-to-human transmission is low. Future assessment of risks of LF and infection control guidelines should take into account the potentially large impact of super-spreaders in human-to-human transmission. Our work highlights several neglected topics in LF research, the occurrence and nature of super-spreading events and aspects of social behavior in transmission and detection.

PubMed Disclaimer

Conflict of interest statement

RFG is affiliated with Zalgen Labs. This does not alter our adherence to all PLOS NTDs policies on sharing data and materials. All other authors have no competing interests.

Figures

Figure 1
Figure 1. Nosocomial outbreaks.
A: Diagrammatic representation of LF cases admitted at Jos Hospital, Nigeria (total duration of the outbreak formula image days), showing period of illness and interrelation among patients . The horizontal bars represent each patient. The x-axis is the time expressed in days from the start of the outbreak, when TS developed the illness (thus time formula image in the calculation corresponds to formula image December 1969). The grey portion of the bars are the period between the onset of the symptoms and admission to hospital; the black portion of the bars are the period between admission to hospital and discharge/death of the patients; the red thin lines are the period of exposure to the index case TS. The green bar represent the time when the patient was at the ward for unrelated illness. Note, the same diagram in present an extra case, JT, which is not included here. This case refers to Dr. Jeanette M. Troup one of the first scientists working on Lassa Fever Virus, who contracted the disease from an autopsy accident incurred during examination of one of the fatal cases. B: Diagrammatic representation of LF cases admitted at Zorzor Hospital (total duration of the outbreak formula image days), Liberia, showing period of illness and interrelation among patients . C: As in Fig. 1.A, but the periods of illness (symptoms plus time at hospital) are randomly permuted. The contact network is kept the same. D: An example of how the time formula image was calculated. In this particular case formula image if formula image and formula image otherwise, where formula image is the time when case formula image is no longer exposed to case formula image.
Figure 2
Figure 2. Epidemic curve.
Daily number of referred/visiting patients at KGH (confirmed cases only) from the formula image of April formula image to the formula image of January formula image, .
Figure 3
Figure 3. Individual effective reproduction number and generation time.
Box-plot for the individual formula image for the nosocomial outbreak described in based on the formula image permutations of the duration of illness. It shows the first and third percentiles, the minimum and maximum values, the median, and outliers (red dots). The dashed line represents the case when the effective reproduction number is equal to formula image. A: nosocomial outbreak in Jos . B: nosocomial outbreak in Zorzor . C: Distribution of generation time for the two nosocomial outbreaks. The statistics are based on the formula image permutations of the duration of illness. D: Distribution of generation time for extra-nosocomial cases. The statistics are based on the formula image permutations of the duration of illness.
Figure 4
Figure 4. Contribution of human-to-human transmission.
Mean value of the total effective reproduction number, formula image and its daily mean, formula image, for the KGH epidemic curve vs the proportion formula image of cases due to human-to-human transmission (blue line). The shaded grey area covers the range between the formula image and formula image percentiles in formula image and/or formula image; the dashed red line represents the mean, nosocomial, effective reproduction number. A and B: formula image and formula image based on the full networks (in Jos and in Zorzor) of nosocomial cases; formula image days. C and D: formula image and formula image based on the extra-nosocomial cases in Jos; formula image days.
Figure 5
Figure 5. Impact of super-spreaders I.
A: Distribution of all individual formula image for both nosocomial outbreaks, based on the formula image permutations of the duration of illness. Mean value of the joint data: formula image, median: formula image, maximum: formula image, proportion of cases when formula image: formula image, proportion of cases when formula image: formula image. B: Distribution of the effective reproduction number for cases of hospitalized patients in KGH for different values of the contribution of human-to-human transmission, formula image, the corresponding data for the extra-nosocomial (formula image permutation based on formula image, formula image, formula image, formula image, formula image cases in Jos) and all nosocomial outbreaks (based on all Jos and Zorzor cases) are also shown. C: Distribution of the total effective reproduction number, i.e. the average number of cases during the entire duration of the epidemic for different values the contribution of human-to-human transmission, formula image.
Figure 6
Figure 6. Impact of super-spreaders II.
A: proportion of cases when the individual effective reproduction number formula image is greater than one. (i.e. the ratio of the cardinalities of formula image and formula image, where formula image is set of all simulated formula image and formula image the subset of cases when formula image is greater than one). B: the expected, relative number of cases generated by this proportion. (i.e. the fraction of the areas of formula image)

References

    1. Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, et al. (2014) Lassa fever in post-conflict Sierra Leone. PLoS Neglected Tropical Diseases 8: e2748. - PMC - PubMed
    1. Carey D, Kemp G, White H, Pinneo L, Addy R, et al. (1972) Lassa fever epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 66: 402–408. - PubMed
    1. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March–April 1972. The American Journal of Tropical Medicine and Hygiene 22: 773–9. - PubMed
    1. Frame JD, Baldwin JM, Gocke DJ, Troup JM (1970) Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. The American Journal of Tropical Medicine and Hygiene 19: 670–6. - PubMed
    1. Rose J (1957) An outbreak of encephalomyelitis in Sierra Leone. The Lancet 270: 914–916. - PubMed

Publication types